from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3844/-

LFCtreatmentdescriptionclass of inhibitor

-0.165

Amikacinug/mL Amikacintranslation

-0.429

Cap5-10ug/mL Capreomycintranslation

-0.269

Rox10-50 ug/mL Roxithromycintranslation

-0.135

SM2-5 ug/mL Streptomycintranslation

-0.268

Tet5-10 ug/mL Tetracyclinetranslation

-0.162

Rif0.2-5ug/mL Rifampicintranscription

-0.156

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.175

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.315

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.329

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.291

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.215

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.547

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.523

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.073

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.763

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.078

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.349

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.302

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.626

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.798

Nigericin50 uM Nigericinrespiration

-0.424

TRC10-150 ug/mL Triclosanrespiration

1.197

TRZ10-25 ug/mL Thioridazinerespiration

2.968

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.668

menadione6-10 ug/mL Menadionerespiration

-0.769

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.695

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.239

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.752

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.005

NRP_1Non-replicating persistence stage 1dosRassociated

-0.478

Amp0.2mg/mL AmpicillincellWall

-0.096

Cephalexin20-100 ug/mL CephalexincellWall

-1.131

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.700

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.335

EMB10-20 ug/mL EthambutolcellWall

-1.711

Eta12-40 ug/mL EthionamidecellWall

-0.334

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.617

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.817

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.046

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.414

BZA0.12 mg/mL BenzamidearomaticAmides

0.573

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.174

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.533

H2O24 mM hydrogen peroxideDNAdamaging

-0.422

Levo10 ug/mL LevofloxacinDNAdamaging

-0.062

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.454

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.151

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.059

UVUV-irradiationDNAdamaging

1.378

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.824

Antimycin12.5-50 ug/mL Antimycin A?

0.129

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.748

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.326

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.734

PA8240.2-2 ug/mL PA-824?

0.422

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.118

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.503

Verapamil50 uM Verapamil?

-0.382

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.162

methoxatin10-20 ug/mL Methoxatin?